ChromoCure, Inc. (KKUR)
- Previous Close
0.0000 - Open
0.0000 - Bid --
- Ask --
- Day's Range
0.0000 - 0.0000 - 52 Week Range
0.0000 - 0.0000 - Volume
500,000 - Avg. Volume
753,333 - Market Cap (intraday)
8,200 - Beta (5Y Monthly) 28.46
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0000 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
ChromoCure, Inc. develops and provides proprietary cancer detection systems. The company offers Chromosomal Scanner Series 200, a cancer detection system to measure the genomic characteristic found in 100% of all cancers and never found in normal cells. It also applies its science and technology to non-toxic and non-invasive approaches to cancer therapy and cure research. The company was formerly known as Cyberhand Technologies International, Inc. and changed its name to ChromoCure, Inc. in June 2009. ChromoCure, Inc. was incorporated in 2001 and is based in Reno, Nevada.
4
Full Time Employees
December 31
Fiscal Year Ends
--
Sector
--
Industry
Recent News: KKUR
Performance Overview: KKUR
Trailing total returns as of 6/1/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: KKUR
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: KKUR
Valuation Measures
Market Cap
--
Enterprise Value
--
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
--
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-8.06%
Return on Equity (ttm)
--
Revenue (ttm)
--
Net Income Avi to Common (ttm)
-147.24k
Diluted EPS (ttm)
-0.0000
Balance Sheet and Cash Flow
Total Cash (mrq)
19.98k
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
--